Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Herpes simplex virus type-2 assay specificity and male circumcision to reduce herpes simplex virus type-2 acquisition.

Literature DB >> 23221430

Herpes simplex virus type-2 assay specificity and male circumcision to reduce herpes simplex virus type-2 acquisition.

Aaron A R Tobian, Godfrey Kigozi, Maria J Wawer, David Serwadda, Thomas C Quinn, Ronald H Gray.

Abstract

Entities: Disease Species

Mesh：

Year: 2013 PMID： 23221430 PMCID： PMC3787836 DOI： 10.1097/QAD.0b013e32835aa181

Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177

× No keyword cloud information.

19 in total

1. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.

Authors: Jordyn L Gamiel; Aaron A R Tobian; Oliver B Laeyendecker; Steven J Reynolds; Rhoda Ashley Morrow; David Serwadda; Ronald H Gray; Thomas C Quinn
Journal: Clin Vaccine Immunol Date: 2008-03-05

2. Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection.

Authors: Supriya D Mehta; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; Robert C Bailey
Journal: AIDS Date: 2012-06-01 Impact factor: 4.177

3. Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.

Authors: Staffan Görander; Judica Mbwana; Eligius Lyamuya; Teresa Lagergård; Jan-Ake Liljeqvist
Journal: Clin Vaccine Immunol Date: 2006-06

4. The medical benefits of male circumcision.

Authors: Aaron A R Tobian; Ronald H Gray
Journal: JAMA Date: 2011-10-05 Impact factor: 56.272

5. Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.

Authors: Oliver Laeyendecker; Charla Henson; Ronald H Gray; Ruby H-N Nguyen; Bobbi Jo Horne; Maria J Wawer; David Serwadda; Noah Kiwanuka; Rhoda Ashley Morrow; Wayne Hogrefe; Thomas C Quinn
Journal: J Clin Microbiol Date: 2004-04 Impact factor: 5.948

6. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations.

Authors: Eddy van Dyck; Anne Buvé; Helen A Weiss; Judith R Glynn; David W G Brown; Bénédicte De Deken; John Parry; Richard J Hayes
Journal: J Clin Microbiol Date: 2004-07 Impact factor: 5.948

7. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.

Authors: R Ashley-Morrow; J Nollkamper; N J Robinson; N Bishop; J Smith
Journal: Clin Microbiol Infect Date: 2004-06 Impact factor: 8.067

8. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition.

Authors: Wayne Hogrefe; Xin Su; James Song; Rhoda Ashley; Lilly Kong
Journal: J Clin Microbiol Date: 2002-10 Impact factor: 5.948

9. Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision.

Authors: Aaron A R Tobian; Ronald H Gray; Thomas C Quinn
Journal: Arch Pediatr Adolesc Med Date: 2010-01

10. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Authors: Bertran Auvert; Dirk Taljaard; Emmanuel Lagarde; Joëlle Sobngwi-Tambekou; Rémi Sitta; Adrian Puren
Journal: PLoS Med Date: 2005-10-25 Impact factor: 11.069

4 in total